Find Academic Supervisors

James C. LoView profile

Associate Professor

• Cardiometabolic diseases
• Cardiovascular biology
• Adipose tissue function
• +3 more

James C. Lo, M.D., Ph.D., is the Rohr Family Clinical Scholar and Associate Professor of Medicine at Weill Cornell Medical College . As a physician-scientist, he directs a basic research laboratory investigating the molecular basis of cardiometabolic diseases. 2023 : Rohr Family Clinical Scholar 2023 : Associate Professor of Medicine, Weill Cornell Medical College 2021 : Assistant Professor of Medicine, Weill Cornell Medical College Education: 2006 - M.D., University of Chicago Pritzker School of Medicine 2004 - Ph.D., University of Chicago 1998 - B.S., University of Chicago Dr. Lo's research focuses on molecular mechanisms of metabolic diseases with emphasis on: Cardiovascular biology in diabetes and obesity Adipose tissue function and thermogenesis Pancreatic islet physiology in metabolic stress Inter-organ communication networks Novel therapeutic targets for diabetes Cardiac complications in metabolic disorders Complement system in endocrine regulation His lab employs single-cell RNA-seq , genetic models , and multi-omics approaches to study: β cell subpopulations in diabetes Complement receptor signaling Adipose-liver-heart cross-talk Extracellular vesicle-mediated dysfunction Sex-dependent metabolic regulation Scientific Contributions: First to identify adipsin's role in β cell protection Discovered complement system's role in islet function Defined adipose tissue as SARS-CoV-2 target Elucidated mechanisms of obesity-induced arrhythmias Developed cross-species models of metabolic stress Research Funding: Currently holds 8 major grants as Principal Investigator or Key Personnel, including: $2.1M - NIH/NHLBI Mechanisms of Obesity-induced Atrial Fibrillation (2025-2028) $2.8M - NIH/NIDDK NAD+ Metabolism in β Cell Dysfunction (2025-2030) $1.5M - AHA Obesity-Driven Atrial Fibrillation (2024-2027) $1.2M - AHA Zebrafish Heart Regeneration (2023-2026) His laboratory team at the Belfer Research Building (New York, NY) includes post-doctoral fellows, Ph.D. students, medical students, and research technicians working in a collaborative environment.

Teresa A. ZimmersView profile

Professor

• Cancer Cachexia
• Pancreatic Cancer
• Muscle Wasting and Atrophy
• +7 more

Teresa A. Zimmers is a Professor at Indiana University with extensive expertise in cancer cachexia, muscle wasting, and translational oncology. She holds a Ph.D. from The Johns Hopkins University School of Medicine (2001), a B.S. from Massachusetts Institute of Technology (1990), and completed postdoctoral training at the University of Rochester (2001-2003). Dr. Zimmers leads prominent academic initiatives as President of the Cancer Cachexia Society and co-organizer of international conferences including the 2023 Cancer Cachexia Conference and 2024 Keystone Conference. Her multidisciplinary research focuses on: Molecular mechanisms of cancer cachexia and muscle atrophy Sex-specific differences in cancer progression Pancreatic cancer pathophysiology Inflammatory signaling in organ injury Translational approaches for metabolic wasting disorders She maintains active memberships in the American Association for Cancer Research, Shock Society, and Society on Sarcopenia, Cachexia and Wasting Diseases. Honors recognizing her contributions include: Alliance of Distinguished and Titled Professors (Indiana University, 2019) Sigma Xi Honor Society (2019) Cancer Researcher of the Year (Women’s Cancer Association, 2009) Distinguished Investigator Award (University of Miami, 2005)

• Nutrition and Dietetics
• Chronic Disease Management
• Malnutrition
• +9 more

Susan Ash is a prominent academic in the field of nutrition and dietetics, affiliated with the School of Human Movement and Nutrition Sciences at the University of Queensland , within the Faculty of Health and Behavioural Sciences . Her research spans clinical nutrition, professional education, and competency development, with a strong focus on chronic disease management and mental health integration in dietetic practice. Institution: University of Queensland School: Faculty of Health and Behavioural Sciences Department: School of Human Movement and Nutrition Sciences Academic Rank: Professor Her research interests include nutrition in Parkinson’s disease , chronic kidney disease , malnutrition , mental health in dietetic practice , competency-based education , and technology in dietary assessment . She has led the development of national competency standards and mental health curricula for dietitians, emphasizing evidence-based frameworks and professional identity. The 15 most recent articles reflect a consistent trajectory in professional standards , clinical assessment tools , and chronic disease nutrition . Key themes include the validation of confidence scales, global professionalism definitions, and digital dietary methods. Her work bridges clinical practice, education, and policy, contributing significantly to the advancement of dietetic science. Scientific Contributions: Developed the Dietetic Confidence Scale for mental health practice. Co-led national guidelines for nutrition in chronic kidney disease and cancer cachexia. Published extensively on malnutrition in Parkinson’s disease and dialysis patients. Explored digital tools for dietary intake monitoring in diabetes. Susan Ash has supervised several students, including Jamie Sheard and Megan Rollo , and has collaborated widely across Australia. She has contributed to workforce planning, staffing ratios, and productivity studies in allied health. Her work in educational methodology, particularly in assessment and competency development, has shaped dietetic training frameworks nationally. Labs and Teams: She has been part of multidisciplinary research teams involving psychologists (e.g., Jane Shakespeare-Finch), nephrologists, neurologists, and public health researchers. Her collaborations with the Dietitians Association of Australia highlight her role in shaping national policy and professional standards.

Nida Sajid AliView profile

Lecturer

• Clinical Oncology
• Cancer Prognostic Factors
• Pharmacy Practice
• +3 more

Dr. Nida Sajid Ali is a Lecturer at the School of Pharmacy, Monash University, Malaysia. Her research focuses on clinical oncology, particularly prognostic and predictive factors influencing treatment plans and survival outcomes in cancer patients. She also explores broader pharmacy practice issues like medication adherence and patient communication skills training. Her academic journey includes a postgraduate research degree completed in 2017 and a transition to Monash University in 2019. Research interests span cancer treatment modalities, molecular biomarkers (e.g., EGFR mutations), and supportive care strategies for cachexia/malnutrition in oncology patients. Notable contributions include studies on gefitinib efficacy in lung cancer, mHealth adoption patterns, and the impact of smoking on adenocarcinoma outcomes. Her work aligns with UN Sustainable Development Goal 3 (Good Health and Well-being). Publications highlight interdisciplinary approaches combining clinical oncology with pharmacoepidemiology and digital health innovation. She has no listed awards but demonstrates active research collaboration in Malaysia and international journals.

• Molecular Biology
• Neuroscience
• Regenerative Medicine
• +5 more

Quansheng Du is an Associate Professor at the Medical College of Georgia , affiliated with the Department of Neuroscience and Regenerative Medicine and the Department of Neurology . His academic appointments include teaching responsibilities in advanced molecular biology courses such as BIOM 8230 Biology of Proteins in Disease and BIOM 8022 Molecular Cell Biology . Education: Ph.D., Molecular Biology, Wuhan University (1999) MS, Molecular Biology, Wuhan University (1995) Research Interests span molecular mechanisms in neurological diseases, regenerative medicine, and metabolic pathways in cancer cachexia. His work includes studies on genetic disorders (MRKH syndrome), microRNA roles in neuronal survival, purine synthesis inhibition in pulmonary hypertension, and TEAD1 signaling in cardiomyocyte protection. Recent Publications (2021–2024) focus on molecular biology intersections with neuroscience, cardiovascular diseases, and cancer metabolism, with recurring themes in genetic regulation, cellular reprogramming, and metabolic dysregulation.

• Pathology
• Oncology
• Hepatology
• +5 more

Dr. Wenyi Luo is an Assistant Professor of Pathology at Yale School of Medicine, specializing in Anatomic Pathology and GI Pathology. He holds roles such as Director of the Immunohistochemistry Lab and has previously served at the University of Oklahoma Health Sciences Center (OUHSC) as Assistant Professor and Surgical Pathology Rotation Director. His research focuses on liver and gastrointestinal pathology, oncology, and cellular mechanisms in diseases like hepatocellular carcinoma and pancreatic cancer. Education: MD from Peking University Health Science Center (2004), PhD in Genetics from University of Alabama Birmingham (2010), and postdoctoral training at UAB and MD Anderson Cancer Center. Board certified in Anatomic and Clinical Pathology. Research interests include cancer biology, necroptosis regulation, liver fibrosis, and therapeutic strategies for cholestasis and cholangiopathy. His work integrates molecular pathology with clinical outcomes, emphasizing translational applications. Notable contributions include studies on macrophage-cancer cell interactions in pancreatic cachexia and miRNA roles in adipogenesis. Collaborations span hepatology, oncology, and metabolic disorders. He has no listed awards but maintains an active publication record in high-impact journals like Cancer Cell and Gastroenterology . Labs/Teams: Involved in gastrointestinal and liver pathology research at Yale, contributing to interdisciplinary projects in cancer biology and liver disease mechanisms.

James MorizioView profile

Adjunct Professor

• Analog CMOS Microelectronics
• Neural Interfaces
• Acoustofluidics
• +4 more

James Morizio serves as an Adjunct Professor in the Department of Electrical and Computer Engineering at Duke University, leveraging 35+ years of expertise in analog CMOS microelectronics for biomedical applications. His research bridges electrical engineering with neuroscience through disruptive sensor interface technologies for neural recording/stimulation and ultrasonic microfluidics. His educational background includes a Ph.D. in Electrical Engineering from Duke University (1995) M.S. in Electrical Engineering from University of Colorado, Boulder (1984) B.S. in Electrical Engineering from Virginia Polytechnic Institute and State University (1982) Morizio's research focuses on developing high-performance neural interfaces and acoustofluidic systems. Key areas include wireless neural instrumentation for closed-loop electrophysiology, CMOS-based ultrasonic transducers for microfluidic manipulation, and low-power VLSI design for implantable devices. His work emphasizes translating microelectronics innovations into biomedical solutions for neuroscience and diagnostics. His publication portfolio demonstrates consistent contributions to neural engineering and microfluidics, with recent trends showing increased focus on acoustofluidic diagnostics (e.g., AIMDx chip) and osseointegrated neural interfaces for prosthetic control. The research spans fundamental circuit design to translational applications in cancer metabolism and neuroprosthetics. Scientific recognition includes 15-year service award from Triangle BioSystems International/Harvard Bioscience Inc. (2016) Current research is supported by major grants including Neuro-CROWN (ultra-flexible electrode arrays), digital acoustofluidic systems for biomedical automation, and osseointegrated neural interfaces for prosthetic control. His teaching portfolio spans advanced VLSI design and special topics courses, though specific advising roles are not documented. Collaborative work involves interdisciplinary teams in neuroscience and biomedical engineering, particularly through partnerships with Triangle BioSystems International and translational projects using ovine models for neural interface validation.

Isabelle R. MiousseView profile

Assistant Professor

• Cancer Metabolism
• Cancer Epigenetics
• Folate Metabolism
• +5 more

Isabelle R. Miousse is an Assistant Professor at the University of Arkansas for Medical Sciences (UAMS), affiliated with the College of Medicine and the Department of Biochemistry and Molecular Biology. She is also a member of the Winthrop P. Rockefeller Cancer Institute. Her research focuses on cancer metabolism and epigenetics, particularly the role of methionine in DNA/histone methylation in tumors. She earned her Ph.D. at McGill University, Canada. Research Interests: Cancer metabolism with emphasis on methyl donor pathways (folate, vitamin B12, methionine) Differential methionine utilization in cancer vs. normal cells Methionine restriction as a therapeutic strategy KRAS-mutant rectal cancer interactions Immunocompetent murine cancer models Molecular mechanisms of methionine dependence Scientific Awards: NIH/NIGMS COBRE (P20) grant for metabolic research Arkansas Bioscience Institute/UAMS funding for cachexia studies Team Science Award from UAMS Cancer Institute KL2 Mentored Research Career Development Scholar Pilot Award from UAMS College of Medicine Advising & Grants: Dr. Miousse has mentored students like Clai Morehead (MD/PhD candidate) and received funding for projects on methionine restriction with immune checkpoint inhibitors in melanoma, radiation therapy synergy with methionine restriction in rectal cancer, and proteomics studies on melanoma metabolism. Labs & Teams: She works from the Biomedical Research Center 1, B421E office and B410 lab. Her team includes Staff Scientist Sarita Garg and has hosted summer students and research technologists.

• Cancer Cachexia
• Metabolism and Cancer
• Adipose Tissue Physiology
• +3 more

Serkan Kir is an Assistant Professor in the Department of Molecular Biology and Genetics at Koc University. His research focuses on cancer cachexia, metabolism in oncology, and the physiological interactions between adipose tissue and skeletal muscle. He obtained his PhD from UT Southwestern Medical Center (2011) and a Bachelor's degree from Bilkent University (2006). Education: PhD, UT Southwestern Medical Center, 2011 Bachelor's Degree, Bilkent University, 2006 Research Interests: Cancer cachexia, metabolism, and tissue physiology are central themes in his work. He investigates: Mechanisms of tumor-induced muscle wasting Adipose tissue thermogenesis and browning Cytokine signaling (e.g., interleukin-6 family, Oncostatin M) Role of EDA2R-NIK and PTHrP pathways in cachexia Epigenetic and transcriptional regulation in metabolic disorders Therapeutic targeting of HDACs and receptor signaling Recent Publication Trends: His work spans translational cancer biology, metabolic reprogramming during cachexia, and receptor-ligand interactions driving tissue wasting. Key areas include fibroblast growth factor signaling, bile acid metabolism, and interventions for Duchenne muscular dystrophy.

Adam KepecsView profile

Professor

• Computational Neuroscience
• Decision-Making
• Neural Circuits
• +5 more

Adam Kepecs is a Professor of Neuroscience and Professor of Psychiatry at Washington University School of Medicine, where he leads the Kepecs Lab as a BJC Investigator. His research focuses on reverse-engineering the computational and neurobiological processes underlying cognition and decision-making with applications to biological psychiatry and artificial intelligence. Kepecs earned his BSc in Computer Science and Mathematics from Eötvös Loránd University in Budapest, Hungary (1997) and his PhD in Neuroscience from Brandeis University (2002). His research spans multiple areas including neural basis of confidence in decisions, cortical circuits and interneurons, neuromodulatory systems, computational psychiatry, neuro-immune interactions, and neuro-inspired artificial intelligence. His research interests center on understanding the algorithms governing behavior, how specific neural circuits and cell types generate cognition, motivation, and emotion, and how brain-body interactions shape physiology and behavior. He employs a multidisciplinary approach combining quantitative behavioral analysis, high-density electrophysiology and imaging, optogenetics, anatomical tracing, molecular biology, and computational modeling to understand how populations of neurons control behavior and cognitive functions. The most recent publications reveal a strong focus on confidence computation across species, neural mechanisms of decision-making, dopamine signaling in perception and psychosis, neuro-immune interactions in cancer, and developing computational frameworks for translating behavioral phenomena across species. His work bridges fundamental neuroscience with clinical applications, particularly in psychiatric disorders. James and Cathleen Stone Faculty Award, CSHL Kavli Frontiers of Science Fellow Eppendorf and Science prize for Neurobiology, Finalist John Merck Scholar Klingenstein Fellow Alfred P. Sloan Research Fellow McKnight Memory & Cognitive Disorders Award Kepecs leads a multidisciplinary team that brings together researchers from diverse backgrounds to tackle neuroscience's toughest questions. His lab has expanded into biological psychiatry and immunology since joining Washington University, exploring new frontiers in brain-body physiology. They are committed to translating findings from animal models to clinical applications to improve mental health research and care. The Kepecs Lab is known for pioneering a computational behavioral approach to isolate distinct cognitive processes and translate them across species, including establishing a rigorous framework linking human confidence reports to statistical decision confidence.

Irene HigginsonView profile

Professor

• Palliative Care
• Quality of Life Measurement
• Symptom Management
• +7 more

Professor Irene Higginson is a leading academic in palliative care and policy at King's College London, holding the role of Professor of Palliative Care & Policy at the Cicely Saunders Institute within the Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care. She also serves as Director of the Better Health & Care Hub. Her roles include honorary consultant positions at King’s College Hospital NHS Foundation Trust, Guy’s and St Thomas’ NHS Foundation Trust, and Lewisham Hospital. She has held leadership roles such as Executive Dean of her faculty and Director of Research and Innovation at King’s College Hospital Trust. Her research focuses on palliative care quality, symptom management (especially breathlessness and cachexia), and healthcare service evaluation. Notably, she leads the EU-funded BETTER-B programme investigating breathlessness interventions. She is a globally recognized researcher with over 4000 citations and recognition as a Highly Cited Researcher (top 1% in her field). Her work spans clinical trials, outcome measurement (e.g., Palliative Care Outcome Scale), and policy development. Recent studies include pharmacological breathlessness management in COPD and non-cancer conditions, as well as evaluating palliative care access and equity. She contributes to international initiatives like the EAPC White Paper on outcome measurement. Education Background : Public Health and Palliative Medicine training, with prior roles at the London School of Hygiene and Tropical Medicine. Grants & Projects : Leads over 200 projects funded by NIHR, EU, and charities like Cicely Saunders International. Awards : NIHR Senior Investigator (Emeritus), top 30 UK female scientist by citations. Teaching : Supervises PhD students, teaches on MSc palliative care programs, and mentors medical trainees. Her research emphasizes interdisciplinary collaboration, addressing inequities in palliative care access and improving models for multimorbidity and complex conditions. She chairs the NIHR Health and Social Care Delivery Research Programme’s funding committee and directs Cicely Saunders International’s scientific activities.

• Biomedical Engineering
• Tissue Engineering
• Microphysiological Systems
• +5 more

Mark Mondrinos is an Assistant Professor of Biomedical Engineering at Tulane University, affiliated with the School of Science & Engineering. His research focuses on developing microphysiological systems and organoid-based models to study human tissues and diseases, with a particular emphasis on lung, muscle, and interstitial tissues. He integrates confocal microscopy and biochemical analysis to bridge translational gaps in preclinical therapy screening. Academic roles include teaching courses such as Microphysiological Systems (BMEN 6440) and Quantitative Physiology (BMEN 3070/6070). Education & Affiliations: Inaugural Fellow, Center for Engineering Mechanobiology at Penn (2017) Postdoctoral Fellow in Bioengineering, University of Pennsylvania (2014–2016) Postdoctoral Fellow, Temple University School of Medicine (2012–2014) Ph.D. in Biomedical Engineering, Drexel University (2011) B.Sc. Chemical Engineering & Biological Chemistry, Florida State University (2002) Research Focus: His lab engineers biologically-inspired models to study respiratory exposure injuries (e.g., vaping), fibrotic disorders, and muscle injury. Current projects include multi-organ microfluidic models for systemic effects of malignancies like cachexia. Key tools include organ-on-a-chip platforms and advanced imaging techniques. Publications: Recent work spans PKC-delta inhibition in sepsis, tumor microenvironment modeling, and vascularized lung scaffolds. These studies highlight translational applications in drug screening and disease mechanisms. Awards: 2013 Jeanette Piperno Memorial Award 2011 Drexel University Best PhD Dissertation Labs/Teams: His laboratory at Tulane specializes in tissue engineering and microphysiological systems, collaborating with institutions like the University of Pennsylvania's Mechanobiology Center. Ongoing projects aim to advance personalized medicine through organ-on-a-chip technologies.

Sung HanView profile

Associate Professor

• Neuroscience
• Neural Circuits
• Neuropeptide Signaling
• +11 more

Sung Han, PhD, is an Associate Professor at the Salk Institute for Biological Studies, where he leads research in the Clayton Foundation Laboratories for Peptide Biology. He holds the Pioneer Fund Developmental Chair and focuses on understanding the brain’s alarm system—how it detects aversive sensory stimuli and mediates emotional, behavioral, and physiological responses. His work has significant implications for neuropsychiatric disorders such as autism, PTSD, panic disorders, and chronic pain. Education: BS in Genetic Engineering, Kyungpook National University, Korea MS in Neuroscience, Pohang University of Science and Technology, Korea PhD in Neurobiology & Behavior, University of Washington, Seattle Dr. Han’s research interests lie at the intersection of neural circuitry, neuropeptide signaling, and affective neuroscience. He investigates how specific brain circuits—particularly in the brainstem—process threat signals using tools such as optogenetics, chemogenetics, and in vivo imaging. His work emphasizes the role of neuropeptides like CGRP and PACAP in encoding pain, panic, and emotional valence. He aims to uncover fundamental mechanisms that can be targeted for therapeutic interventions in sensory-processing disorders. His recent publications (2021–2025) reveal a strong trend in dissecting neural pathways involved in affective pain, respiratory control, panic-like behavior, and neuropeptide transmission. These studies frequently employ genetically encoded tools and animal models to map and manipulate specific circuits, highlighting a focus on precision neuroscience and translational relevance. Scientific Awards: NIMH Biobehavioral Research Award for Innovative New Scientist (BRAINS), 2018 SFARI Bridge to Independence Award, 2016 Life Sciences Research Foundation Postdoctoral Fellowship, 2015–2018 KBRI Postdoctoral Research Award, Association of Korean Neuroscientists, 2012 Korea Research Foundation Research Grant, 2005 Dr. Han actively mentors students and postdoctoral researchers, though specific names are not listed. His lab benefits from significant grant support, including awards from NIMH and SFARI. He is involved in developing novel tools for monitoring and silencing neuropeptide release, reflecting a strong emphasis on innovation. His work is closely tied to key discoveries at Salk, such as the identification of CGRP by Ron Evans, and he collaborates within a vibrant neuroscience community, including inspiration from Ed Callaway’s work on neural circuit mapping. He is part of a dedicated team studying brainstem circuits and their role in integrating sensory, emotional, and autonomic functions. His lab is at the forefront of using modern neuroscience techniques to decode how the brain responds to threats, with the ultimate goal of developing therapies for neurological and psychiatric conditions.

James G. TidballView profile

Professor

• Muscular Dystrophy
• Immunobiology
• Skeletal Muscle Regeneration
• +5 more

James G. Tidball is a Distinguished Professor in the Department of Integrative Biology and Physiology at the University of California, Los Angeles (UCLA), College of Letters and Science. His research focuses on skeletal muscle wasting, regeneration, and the immunobiology of muscular dystrophy. Dr. Tidball earned his B.S. in Zoology from Duke University (1975) and his Ph.D. from Dalhousie University (1981). His early work at Duke with Professor Steve Wainwright centered on organismal responses to mechanical environments, which evolved into groundbreaking research on myotendinous junctions during postdoctoral studies at Duke. His laboratory investigates how the immune system regulates skeletal muscle injury and repair, with particular emphasis on macrophage phenotypes (M1/M2) in Duchenne muscular dystrophy (DMD). Key discoveries include identifying immune-mediated muscle damage as central to DMD pathology and pioneering work on Klotho protein's role in muscle regeneration and aging. Current NIH-funded projects explore epigenetic mechanisms of Klotho in neonatal/aging muscle and pharmacological manipulation of macrophage-T cell interactions for DMD therapy. Dr. Tidball's publication trends reveal consistent leadership in muscular dystrophy immunobiology, with recent work expanding into aging-related sarcopenia, Klotho-mediated epigenetic regulation, and novel therapeutic strategies targeting immune-muscle crosstalk. His most cited papers establish foundational concepts in immune modulation of muscle pathology. As principal investigator, he directs an active research program supported by multiple NIH grants. His team includes postdoctoral fellows and collaborators focused on macrophage biology, Klotho signaling, and preclinical therapeutic development for muscular dystrophies. The lab maintains specialized facilities for muscle histology, flow cytometry, and transgenic mouse models including mdx (DMD) and aging cohorts.

• Metabolism
• Signal Transduction
• Cancer
• +3 more

David A Guertin is a Professor at UMass Chan Medical School, affiliated with the T.H. Chan School of Medicine and the Program in Molecular Medicine . His research focuses on nutrient sensing, metabolic regulation, and the mTOR pathway, with significant implications in cancer, diabetes, and obesity. Education: BS in Science, Saint Michael's College PhD in Philosophy, University of Massachusetts Medical School Postdoc, Whitehead Institute for Biomedical Research (2009) Guertin's work explores the interplay between nutrient sensing signaling mechanisms and metabolism, particularly through the mTOR pathway. He has contributed to understanding mTOR complex 2 (mTORC2), brown adipose tissue development, and metabolic homeostasis. His research also links altered nutrient sensing to diseases like cancer, diabetes, and tuberculosis. Recent publications highlight his team's analysis of metabolic dependencies in brown adipocytes, mTORC2-AKT signaling, and pathways like PTHrP in pancreatic cancer cachexia. Articles span journals such as Nature Metabolism , Genes & Development , and Cell Reports , emphasizing metabolism, cell biology, and genetic regulation. Scientific Awards: Damon Runyon Cancer Research Fellowship Leukemia & Lymphoma Society Special Fellow NIH/NCI Pathway to Independence Award PEW Scholar Award Charles Hood Foundation Child Health Research Award Leukemia & Lymphoma Research Scholar Guertin's lab offers postdoctoral positions and is part of interdisciplinary programs like the MD/PhD Program and the Diabetes and Endocrinology Research Center . He mentors students and trains researchers in molecular medicine and cancer metabolism.